These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 17318507

  • 1. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I.
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [Abstract] [Full Text] [Related]

  • 2. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
    Cryan JF, O'Leary OF, Jin SH, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I.
    Proc Natl Acad Sci U S A; 2004 May 25; 101(21):8186-91. PubMed ID: 15148402
    [Abstract] [Full Text] [Related]

  • 3. The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.
    O'Leary OF, Bechtholt AJ, Crowley JJ, Valentino RJ, Lucki I.
    Eur Neuropsychopharmacol; 2007 Feb 25; 17(3):215-26. PubMed ID: 16997535
    [Abstract] [Full Text] [Related]

  • 4. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.
    Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I.
    J Pharmacol Exp Ther; 2001 Sep 25; 298(3):1101-7. PubMed ID: 11504807
    [Abstract] [Full Text] [Related]

  • 5. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
    Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):1066-74. PubMed ID: 20562216
    [Abstract] [Full Text] [Related]

  • 6. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
    Dekeyne A, Gobert A, Auclair A, Girardon S, Millan MJ.
    Psychopharmacology (Berl); 2002 Jul 01; 162(2):156-67. PubMed ID: 12110993
    [Abstract] [Full Text] [Related]

  • 7. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ, Dekeyne A, Papp M, La Rochelle CD, MacSweeny C, Peglion JL, Brocco M.
    J Pharmacol Exp Ther; 2001 Aug 01; 298(2):581-91. PubMed ID: 11454919
    [Abstract] [Full Text] [Related]

  • 8. Xylopia aethiopica fruit extract exhibits antidepressant-like effect via interaction with serotonergic neurotransmission in mice.
    Biney RP, Benneh CK, Ameyaw EO, Boakye-Gyasi E, Woode E.
    J Ethnopharmacol; 2016 May 26; 184():49-57. PubMed ID: 26902831
    [Abstract] [Full Text] [Related]

  • 9. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
    Jacobsen JP, Nielsen EØ, Hummel R, Redrobe JP, Mirza N, Weikop P.
    Psychopharmacology (Berl); 2008 Aug 26; 199(2):137-50. PubMed ID: 18496675
    [Abstract] [Full Text] [Related]

  • 10. Antidepressant-like effects in various mice strains in the tail suspension test.
    Ripoll N, David DJ, Dailly E, Hascoët M, Bourin M.
    Behav Brain Res; 2003 Aug 14; 143(2):193-200. PubMed ID: 12900045
    [Abstract] [Full Text] [Related]

  • 11. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
    Andreasen JT, Redrobe JP.
    Behav Brain Res; 2009 Jan 30; 197(1):150-6. PubMed ID: 18786574
    [Abstract] [Full Text] [Related]

  • 12. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
    Dekeyne A, Gobert A, Iob L, Cistarelli L, Melon C, Millan MJ.
    Psychopharmacology (Berl); 2001 Nov 30; 158(2):213-8. PubMed ID: 11702096
    [Abstract] [Full Text] [Related]

  • 13. The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals.
    Suarez-Roca H, Cubeddu LX.
    J Pharmacol Exp Ther; 2002 Jul 30; 302(1):174-9. PubMed ID: 12065714
    [Abstract] [Full Text] [Related]

  • 14. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.
    Wong EH, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA.
    Biol Psychiatry; 2000 May 01; 47(9):818-29. PubMed ID: 10812041
    [Abstract] [Full Text] [Related]

  • 15. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
    Sarkisyan G, Roberts AJ, Hedlund PB.
    Behav Brain Res; 2010 May 01; 209(1):99-108. PubMed ID: 20097233
    [Abstract] [Full Text] [Related]

  • 16. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Gobert A, Brocco M, Dekeyne A, Di Cara B, Bouchez G, Lejeune F, Gannon RL, Millan MJ.
    Neuropsychopharmacology; 2009 Mar 01; 34(4):1039-56. PubMed ID: 18830239
    [Abstract] [Full Text] [Related]

  • 17. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test.
    Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I.
    Psychopharmacology (Berl); 1999 Nov 01; 147(2):162-7. PubMed ID: 10591883
    [Abstract] [Full Text] [Related]

  • 18. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M.
    Acta Psychiatr Scand Suppl; 2000 Nov 01; 402():28-36. PubMed ID: 10901156
    [Abstract] [Full Text] [Related]

  • 19. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
    Takahashi E, Katayama M, Niimi K, Itakura C.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):149-56. PubMed ID: 18571641
    [Abstract] [Full Text] [Related]

  • 20. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties.
    Artaiz I, Zazpe A, Innerárity A, Del Olmo E, Díaz A, Ruiz-Ortega JA, Castro E, Pena R, Labeaga L, Pazos A, Orjales A.
    Psychopharmacology (Berl); 2005 Nov 28; 182(3):400-13. PubMed ID: 16032410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.